Dr. Yaw Asare-Aboagye (DVM, MS) is the Regional Clinical Operations Head for Drugs for Neglected Diseases Initiative (DNDi), Africa Regional Office where he leads the Clinical operations and Biometrics functions in the Nairobi, Kenya office. In this role, Yaw is responsible for leading a team of researchers working to develop treatments for tropical diseases that have been largely ignored by the major pharmaceutical companies. Prior to joining DNDi, Yaw was an Executive Director for Global Clinical Sciences at Biomarin, a biotechnology company specializing in the development of drugs for ultra-rare diseases. At Biomarin, Yaw was part of a team that successfully received approval for four drugs globally in six years. Yaw has also held leadership positions for some of the largest pharmaceutical and biotechnology companies starting with Bristol Myers Squibb, Immunex, Amgen and United Therapeutics. Yaw is currently a lifetime trustee of the Ashesi University Foundation, a Seattle based foundation that supports the Ashesi University in Ghana. Yaw holds the Doctor of Veterinary Medicine degree (DVM) from the University of Ibadan in Nigeria and an MS degree in Biometrics from Louisiana State University School of Public Health, New Orleans, Louisiana, USA.